| dMMR Colorectal Carcinoma studied in …STUDIED_INderived12 of 12show fewer |
|---|
| → studied in | NCT07689812NA · not yet recruiting A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors. · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05520099active not recruiting Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07327489recruiting Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05239546Phase 2 · recruiting Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06152523Phase 2 · withdrawn Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409844Phase 2 · not yet recruiting Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06414304completed Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613165recruiting Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301557Phase 2 · unknown PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06262581Phase 2 · unknown Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04244552Phase 1 · terminated A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05815290Phase 2 · unknown Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer · condition mapped ALIAS · 12 trials mapped (6 active) | — | — | dMMR Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |